Alimera Sciences Inc (ALIM)
3.34
-0.10
(-2.91%)
USD |
NASDAQ |
Apr 19, 16:00
3.45
+0.11
(+3.29%)
After-Hours: 20:00
Alimera Sciences Cash from Operations (TTM): -14.26M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -14.26M |
September 30, 2023 | -18.28M |
June 30, 2023 | -10.37M |
March 31, 2023 | -5.971M |
December 31, 2022 | -9.975M |
September 30, 2022 | -14.41M |
June 30, 2022 | -15.23M |
March 31, 2022 | -6.936M |
December 31, 2021 | -3.224M |
September 30, 2021 | 1.196M |
June 30, 2021 | 1.78M |
March 31, 2021 | -5.242M |
December 31, 2020 | -2.193M |
September 30, 2020 | -1.508M |
June 30, 2020 | -3.258M |
March 31, 2020 | -3.888M |
December 31, 2019 | -4.152M |
September 30, 2019 | -3.914M |
June 30, 2019 | -3.827M |
March 31, 2019 | -6.221M |
December 31, 2018 | -11.55M |
September 30, 2018 | -13.92M |
June 30, 2018 | -14.28M |
March 31, 2018 | -13.75M |
December 31, 2017 | -12.87M |
Date | Value |
---|---|
September 30, 2017 | -13.57M |
June 30, 2017 | -17.90M |
March 31, 2017 | -22.53M |
December 31, 2016 | -25.10M |
September 30, 2016 | -31.59M |
June 30, 2016 | -31.91M |
March 31, 2016 | -37.40M |
December 31, 2015 | -45.36M |
September 30, 2015 | -45.62M |
June 30, 2015 | -41.76M |
March 31, 2015 | -32.78M |
December 31, 2014 | -24.30M |
September 30, 2014 | -24.88M |
June 30, 2014 | -28.92M |
March 31, 2014 | -34.26M |
December 31, 2013 | -37.82M |
September 30, 2013 | -34.78M |
June 30, 2013 | -30.22M |
March 31, 2013 | -25.54M |
December 31, 2012 | -21.18M |
September 30, 2012 | -19.06M |
June 30, 2012 | -20.20M |
March 31, 2012 | -21.14M |
December 31, 2011 | -20.72M |
September 30, 2011 | -22.18M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-18.28M
Minimum
Sep 2023
1.78M
Maximum
Jun 2021
-6.508M
Average
-4.152M
Median
Dec 2019
Cash from Operations (TTM) Benchmarks
Eli Lilly and Co | 4.240B |
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -19.00M |